Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Queensland Health
Express Scripts
Argus Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Subscribe

« Back to Dashboard

Details for Patent: ➤ Subscribe

Title: Nucleic acid encoding a NF-.kappa.B activation regulatory protein, I.kappa.B.beta.
Abstract:The present invention provides a novel polypeptide, I.kappa.B-.beta., which binds to and affects NF-.kappa.B gene activation. Also provided is the nucleotide sequence encoding I.kappa.B-.beta. and methods of identifying compositions which affect I.kappa.B-.beta./NF-.kappa.B complexes. Methods of treatment of disorders associated with NF-.kappa.B induced gene activation are also described herein.
Inventor(s): Ghosh; Sankar (Madison, CT)
Assignee: Yale University (New Haven, CT)
Filing Date:Nov 13, 1996
Application Number:08/748,428
Claims:1. An isolated nucleic acid sequence which encodes the amino acid sequence set forth as SEQ ID NO:2.

2. The nucleic acid sequence of claim wherein the nucleic acid sequence comprises the sequence set forth as SEQ ID NO:1.

3. An isolated nucleic acid sequence, wherein the nucleic acid sequence is selected from the group consisting of:

(a) the nucleic acid sequence set forth as SEQ ID NO:1;

(b) the nucleic acid sequence set forth as SEQ ID NO:1, which nucleic acid sequence is an RNA sequence; and

(c) the nucleic acid sequence that is the full length complement of the nucleic acid sequence set forth as SEQ ID NO:1.

4. A recombinant expression vector containing the nucleic acid sequence of claim 1.

5. A host cell containing the recombinant expression vector of claim 4.

6. The vector of claim 4, wherein the vector is a virus.

7. The vector of claim 6, wherein the virus is an RNA virus.

8. The vector of claim 7, wherein the RNA virus is a retrovirus.

9. The vector of claim 4, wherein the vector is a plasmid.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Cantor Fitzgerald
Daiichi Sankyo
Fish and Richardson
US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: